| scholarly article | Q13442814 |
| P50 | author | Lars Maegdefessel | Q38323768 |
| Nicholas J. Leeper | Q92979518 | ||
| P2860 | cites work | An integrated encyclopedia of DNA elements in the human genome | Q22122150 |
| Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development | Q24303139 | ||
| MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion | Q24305799 | ||
| miR-145 and miR-143 regulate smooth muscle cell fate and plasticity | Q24311186 | ||
| Elastin is an essential determinant of arterial morphogenesis | Q24321276 | ||
| The product of the H19 gene may function as an RNA | Q24599284 | ||
| Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health | Q24604190 | ||
| The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease | Q24606673 | ||
| MicroRNA-26a is a novel regulator of vascular smooth muscle cell function | Q24624403 | ||
| The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r | Q24633774 | ||
| MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation | Q24650539 | ||
| A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia | Q24650572 | ||
| Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype | Q24658407 | ||
| The role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decision | Q26775618 | ||
| The H19 Long non-coding RNA in cancer initiation, progression and metastasis - a proposed unifying theory | Q26780223 | ||
| Genome regulation by long noncoding RNAs. | Q27691812 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| miRNA-34a reduces neointima formation through inhibiting smooth muscle cell proliferation and migration | Q28116054 | ||
| Long non-coding RNAs: insights into functions | Q28131764 | ||
| MicroRNA-1 inhibits myocardin-induced contractility of human vascular smooth muscle cells | Q28282084 | ||
| MicroRNA-1 Regulates Smooth Muscle Cell Differentiation by Repressing Kruppel-Like Factor 4 | Q28291928 | ||
| Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation | Q28297726 | ||
| Dicer is essential for mouse development | Q28511142 | ||
| A micropeptide encoded by a putative long noncoding RNA regulates muscle performance | Q28513835 | ||
| Kruppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids | Q28579612 | ||
| Myocardin regulates vascular response to injury through miR-24/-29a and platelet-derived growth factor receptor-β | Q28585806 | ||
| Upregulated sirtuin 1 by miRNA-34a is required for smooth muscle cell differentiation from pluripotent stem cells | Q28587605 | ||
| MiR-133a modulates osteogenic differentiation of vascular smooth muscle cells | Q38314602 | ||
| Circular RNAs in heart failure | Q38739402 | ||
| Long Noncoding RNAs: From Clinical Genetics to Therapeutic Targets? | Q38769281 | ||
| Activated mineralocorticoid receptor regulates micro-RNA-29b in vascular smooth muscle cells | Q38806758 | ||
| Noncoding RNAs in smooth muscle cell homeostasis: implications in phenotypic switch and vascular disorders | Q38816280 | ||
| Extracellular Matrix in Atherosclerosis: Hyaluronan and Proteoglycans Insights | Q38860078 | ||
| Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches | Q38930469 | ||
| BRG1 expression is increased in thoracic aortic aneurysms and regulates proliferation and apoptosis of vascular smooth muscle cells through the long non-coding RNA HIF1A-AS1 in vitro | Q38990258 | ||
| Cholesterol crystallization in human atherosclerosis is triggered in smooth muscle cells during the transition from fatty streak to fibroatheroma | Q39047738 | ||
| MicroRNA therapeutics: towards a new era for the management of cancer and other diseases | Q39139786 | ||
| Cell Death in the Vessel Wall: The Good, the Bad, the Ugly. | Q39388843 | ||
| microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart | Q40036277 | ||
| Role of miR-195 in aortic aneurysmal disease | Q40036293 | ||
| A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. | Q40467498 | ||
| MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation | Q41166615 | ||
| MYOSLID Is a Novel Serum Response Factor-Dependent Long Noncoding RNA That Amplifies the Vascular Smooth Muscle Differentiation Program | Q41633123 | ||
| miR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction | Q41659413 | ||
| A novel regulatory mechanism of the bone morphogenetic protein (BMP) signaling pathway involving the carboxyl-terminal tail domain of BMP type II receptor | Q42412062 | ||
| Defect in insulin-like growth factor-1 survival mechanism in atherosclerotic plaque-derived vascular smooth muscle cells is mediated by reduced surface binding and signaling | Q43604802 | ||
| Platelet-derived growth factor-BB represses smooth muscle cell marker genes via changes in binding of MKL factors and histone deacetylases to their promoters | Q44923453 | ||
| Reconciling Smooth Muscle Cell Oligoclonality and Proliferative Capacity in Experimental Atherosclerosis | Q45048571 | ||
| MicroRNA-205 regulates the calcification and osteoblastic differentiation of vascular smooth muscle cells | Q46284267 | ||
| TGFβ Triggers miR-143/145 Transfer From Smooth Muscle Cells to Endothelial Cells, Thereby Modulating Vessel Stabilization | Q46491669 | ||
| Dicer generates a regulatory microRNA network in smooth muscle cells that limits neointima formation during vascular repair | Q48358059 | ||
| dNK derived IFN-γ mediates VSMC migration and apoptosis via the induction of LncRNA MEG3: A role in uterovascular transformation. | Q50911730 | ||
| Altered DNA Methylation of Long Noncoding RNA H19 in Calcific Aortic Valve Disease Promotes Mineralization by Silencing NOTCH1. | Q51358655 | ||
| Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a murine model of Marfan syndrome. | Q53042878 | ||
| The biogenesis and emerging roles of circular RNAs. | Q53236217 | ||
| MiR-138 promotes smooth muscle cells proliferation and migration in db/db mice through down-regulation of SIRT1. | Q53466520 | ||
| Long noncoding RNA H19-derived miR-675 aggravates restenosis by targeting PTEN. | Q53588450 | ||
| miR-29b participates in early aneurysm development in Marfan syndrome. | Q54337183 | ||
| Long Noncoding RNA Meg3 Controls Endothelial Cell Aging and Function: Implications for Regenerative Angiogenesis. | Q54771075 | ||
| Chronic Apoptosis of Vascular Smooth Muscle Cells Accelerates Atherosclerosis and Promotes Calcification and Medial Degeneration | Q56987890 | ||
| MicroRNA-29 in Aortic Dilation: Implications for Aneurysm Formation | Q58816127 | ||
| A Role for miR-145 in Pulmonary Arterial Hypertension | Q63916426 | ||
| Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors | Q71934600 | ||
| Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy | Q72225398 | ||
| Apoptosis in the atherosclerotic plaque: quantitative and qualitative aspects | Q77380909 | ||
| Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques | Q77792623 | ||
| MicroRNA-130a mediates proliferation of vascular smooth muscle cells in hypertension | Q84554499 | ||
| Down-regulation of miR-23b induces phenotypic switching of vascular smooth muscle cells in vitro and in vivo | Q87347536 | ||
| Upregulation of let-7a inhibits vascular smooth muscle cell proliferation in vitro and in vein graft intimal hyperplasia in rats | Q88130245 | ||
| Dicer is required for embryonic angiogenesis during mouse development | Q28591059 | ||
| A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response | Q28592069 | ||
| Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs | Q28941769 | ||
| SMAD proteins control DROSHA-mediated microRNA maturation | Q28941771 | ||
| Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis | Q29547607 | ||
| Long noncoding RNAs: functional surprises from the RNA world | Q29615826 | ||
| Modular regulatory principles of large non-coding RNAs | Q29617829 | ||
| Progress and challenges in translating the biology of atherosclerosis | Q29619982 | ||
| Circular RNAs are a large class of animal RNAs with regulatory potency | Q29620042 | ||
| microRNA-1 regulates sarcomere formation and suppresses smooth muscle gene expression in the mammalian heart. | Q30090181 | ||
| Vascular Smooth Muscle Cells in Atherosclerosis | Q30277316 | ||
| KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis | Q30299921 | ||
| Cooperative binding of KLF4, pELK-1, and HDAC2 to a G/C repressor element in the SM22α promoter mediates transcriptional silencing during SMC phenotypic switching in vivo | Q30417509 | ||
| Interleukin-1β modulates smooth muscle cell phenotype to a distinct inflammatory state relative to PDGF-DD via NF-κB-dependent mechanisms | Q30421700 | ||
| Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle | Q30436555 | ||
| Conditional deletion of Krüppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury | Q30440313 | ||
| Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro | Q30444292 | ||
| Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease | Q30454529 | ||
| miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development | Q30596758 | ||
| Identification and initial functional characterization of a human vascular cell-enriched long noncoding RNA. | Q33624033 | ||
| Molecular basis for antagonism between PDGF and the TGFbeta family of signalling pathways by control of miR-24 expression | Q33697043 | ||
| Circular RNAs: Biogenesis, Function and Role in Human Diseases. | Q33766123 | ||
| Smooth muscle miRNAs are critical for post-natal regulation of blood pressure and vascular function | Q33883484 | ||
| MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function | Q33893114 | ||
| A differentiation-based microRNA signature identifies leiomyosarcoma as a mesenchymal stem cell-related malignancy | Q34033361 | ||
| The imprinted H19 lncRNA antagonizes let-7 microRNAs. | Q34038293 | ||
| MicroRNA-155 regulates angiotensin II type 1 receptor expression and phenotypic differentiation in vascular adventitial fibroblasts | Q34132935 | ||
| Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques | Q34218450 | ||
| Natural antisense transcript for hyaluronan synthase 2 (HAS2-AS1) induces transcription of HAS2 via protein O-GlcNAcylation. | Q34355572 | ||
| LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity | Q34435119 | ||
| Rapid evolution of noncoding RNAs: lack of conservation does not mean lack of function | Q34467942 | ||
| miR-146a and Krüppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation | Q34506077 | ||
| Myogenic factors that regulate expression of muscle-specific microRNAs | Q34531532 | ||
| H19 long noncoding RNA controls the mRNA decay promoting function of KSRP. | Q34601079 | ||
| Role for miR-204 in human pulmonary arterial hypertension | Q34681312 | ||
| Regulation of apoptosis by long non-coding RNA HIF1A-AS1 in VSMCs: implications for TAA pathogenesis. | Q34733096 | ||
| Role of Dicer in posttranscriptional RNA silencing | Q34749330 | ||
| Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks | Q34825023 | ||
| The miR-143/145 cluster is a novel transcriptional target of Jagged-1/Notch signaling in vascular smooth muscle cells | Q35150176 | ||
| Low expression of lncRNA-GAS5 is implicated in human primary varicose great saphenous veins | Q35217325 | ||
| Transforming growth factor-beta1 (TGF-beta1) utilizes distinct pathways for the transcriptional activation of microRNA 143/145 in human coronary artery smooth muscle cells | Q35314346 | ||
| Cystic medial degeneration of the aorta is associated with p53 accumulation, Bax upregulation, apoptotic cell death, and cell proliferation. | Q35373696 | ||
| Reducing In-Stent Restenosis: Therapeutic Manipulation of miRNA in Vascular Remodeling and Inflammation | Q35649420 | ||
| MicroRNA-663 regulates human vascular smooth muscle cell phenotypic switch and vascular neointimal formation | Q35957299 | ||
| Endothelial Cells Can Regulate Smooth Muscle Cells in Contractile Phenotype through the miR-206/ARF6&NCX1/Exosome Axis | Q35975556 | ||
| Local MicroRNA Modulation Using a Novel Anti-miR-21-Eluting Stent Effectively Prevents Experimental In-Stent Restenosis | Q36004612 | ||
| Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells | Q36190972 | ||
| MicroRNA-210 Enhances Fibrous Cap Stability in Advanced Atherosclerotic Lesions | Q36206145 | ||
| The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. | Q36356007 | ||
| MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages | Q36357815 | ||
| H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b. | Q36557258 | ||
| Locus unlinked to alpha-fetoprotein under the control of the murine raf and Rif genes | Q36592693 | ||
| Conditional deletion of Dicer in vascular smooth muscle cells leads to the developmental delay and embryonic mortality | Q36678561 | ||
| Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. | Q36785271 | ||
| H19 Long Noncoding RNA Regulates Intestinal Epithelial Barrier Function via MicroRNA 675 by Interacting with RNA-Binding Protein HuR. | Q36811569 | ||
| miR-424/322 regulates vascular smooth muscle cell phenotype and neointimal formation in the rat. | Q36851322 | ||
| A Role for the Long Noncoding RNA SENCR in Commitment and Function of Endothelial Cells | Q36924316 | ||
| Chronic miR-29 antagonism promotes favorable plaque remodeling in atherosclerotic mice | Q36955987 | ||
| Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells | Q37149254 | ||
| Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis | Q37175720 | ||
| Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster | Q37328540 | ||
| Downregulation of long non-coding RNA H19 promotes P19CL6 cells proliferation and inhibits apoptosis during late-stage cardiac differentiation via miR-19b-modulated Sox6. | Q37431570 | ||
| Role of long non-coding RNA-RNCR3 in atherosclerosis-related vascular dysfunction | Q37482738 | ||
| Aberrantly expressed lncRNAs in primary varicose great saphenous veins | Q37538131 | ||
| Life and death in the atherosclerotic plaque | Q37774221 | ||
| ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. | Q37801219 | ||
| Long noncoding RNAs and human disease | Q37873053 | ||
| The emerging role of microRNAs in cardiovascular disease | Q38243731 | ||
| MicroRNA regulation of vascular smooth muscle function and phenotype: early career committee contribution | Q38292581 | ||
| P577 | publication date | 2017-12-29 | |
| P1433 | published in | Cardiovascular Research | Q4642329 |
| P1476 | title | Non-coding RNAs: key regulators of smooth muscle cell fate in vascular disease |
| Q89892388 | Aortic Aneurysms and Dissections Series |
| Q90379386 | Circulating Long Noncoding RNA LIPCAR Acts as a Novel Biomarker in Patients with ST-Segment Elevation Myocardial Infarction |
| Q94453306 | Downregulated lncRNA UCA1 accelerates proliferation and migration of vascular smooth muscle cells by epigenetic regulation of MMP9 |
| Q91864017 | Epigenetic influences on genetically triggered thoracic aortic aneurysm |
| Q90655606 | Expression of Long Noncoding RNA LIPCAR Promotes Cell Proliferation, Cell Migration, and Change in Phenotype of Vascular Smooth Muscle Cells |
| Q57822561 | Impact of miRNA in Atherosclerosis |
| Q90169632 | Long noncoding RNA GAS5 induces abdominal aortic aneurysm formation by promoting smooth muscle apoptosis |
| Q91844720 | MicroRNA-125b in vascular diseases: An updated systematic review of pathogenetic implications and clinical applications |
| Q64104854 | MicroRNA-25 Protects Smooth Muscle Cells against Corticosterone-Induced Apoptosis |
| Q57787196 | Noncoding RNAs in the Regulatory Network of Hypertension |
| Q91577859 | Role of Noncoding RNAs in the Pathogenesis of Abdominal Aortic Aneurysm |
| Q93139190 | Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics |
Search more.